Navigation Links
Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
Date:9/25/2008

Awards for best biotechnology and best pharmaceutical agents honored outstanding drugs for treating cancer, HIV/AIDS and other life-altering diseases

NEW YORK, Sept. 25 /PRNewswire-USNewswire/ --- Prix Galien USA 2008 (http://www.prix-galien-usa.com) last night recognized the innovations and ingenuities of biotechnological and pharmaceutical companies and researchers for the development of drugs that address pervasive illness and diseases including cancer, HIV/AIDS, hypertension and others.

At the ceremony, Sheldon Segal, distinguished scientist at the Population Council, received the Pro Bono Humanum Award for spearheading an innovative, collaborative and charitable coalition approach toward developing and distributing implantable hormone delivery systems used for birth control and family planning, improving the quality of life of more than 8 million women worldwide. The award, which was given by Elie Wiesel, also recognized other coalition members the late Judah Folkman of Harvard University, the Rockefeller Brothers Foundation, Dow-Corning and Wyeth for their contributions to this science-based global effort to improve reproductive health, especially in underserved countries.

"The therapeutic agents recognized by Prix Galien USA represent the best of the best, impacting such conditions as cancer, HIV/AIDS and human debility, and serve as examples of what the biopharmaceutical industry can do to improve the human condition," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal. "We are living in the midst of a biological revolution and the breakthrough agents honored by the Prix Galien USA illustrate the substantial research and development necessary to bring the fruits of that revolution in molecular medicine to the clinic."

The Prix Galien USA 2008 winners include:

Best Pharmaceutical Agent (Small Molecule)

-- Selzentry(TM) Hidden List (Pfizer Inc.) -- This treatment is

used to treat a strain of HIV called "CCR5-tropic HIV-1

detectable," a strain that was previously resistant to other

therapies. Selzentry works by preventing HIV from binding to T-cells, a

necessary step for the virus to spread and replicate throughout the

body.

-- Isentress(R) (Merck & Co., Inc.) -- Isentress is the first drug in a

new class of HIV medications called "integrase inhibitors,"

that works by preventing HIV from taking over human cells and stopping

viral replication.

Best Biotechnology Agent

-- Soliris(TM) (Alexion Pharmaceuticals, Inc.) -- This is the first and

only FDA-approved drug to treat Paroxysmal Nocturnal Hemoglobinuria, a

rare disease that usually leads to a painful death by age 10.

-- INFUSE(R) (Wyeth) -- Hidden List INFUSE is a bone graft

device that incorporates a synthesized therapeutic protein to promote

bone healing.

Special Therapeutic Development

-- The Celgene Corporation for Revlimid(R) -- Taken orally, this cancer

medication primes the immune system for killing cancer cells.

The Prix Galien Award (http://www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA awards committee of 11 individuals includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals.


'/>"/>
SOURCE Prix Galien USA
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
2. U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship
3. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
4. State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales
5. Presidents Award Recognizes Hospitals Response to Bridge Collapse
6. SFMS David Perlman Award For Excellence in Medical/Health Reporting Recognizes Local Reporters
7. PA Agriculture Official Recognizes Healthy Garden at Lehigh County School
8. AVMA Recognizes Public Veterinarians Urges Congressional Action
9. President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House
10. Sierra Tucson Recognizes Professionals at Gratitude for Giving Breakfast
11. EPA Recognizes Fort Wayne Community Schools for Reducing Diesel Emissions From Its School Buses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: